A. A. Spector, Essentiality of fatty acids, Lipids, vol.39, issue.S1, 1999.
DOI : 10.1007/BF02562220

J. E. Kinsella, B. Lokesh, and R. A. Stone, Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms, Am J Clin Nutr Review, vol.52, pp.21-28, 1990.

M. Croset, A. Sala, G. Folco, and M. Lagarde, Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988.
DOI : 10.1016/0006-2952(88)90782-4

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.25-382, 2011.
DOI : 10.1096/fj.10-161836

URL : https://hal.archives-ouvertes.fr/inserm-00517396

C. N. Serhan, Pro-resolving lipid mediators are leads for resolution physiology, Nature, vol.1821, issue.7503, pp.92-101, 2014.
DOI : 10.1038/nature13479

D. Kromhout and J. De-goede, Update on cardiometabolic health effects of ??-3 fatty acids, Current Opinion in Lipidology, vol.25, issue.1, pp.85-90, 2014.
DOI : 10.1097/MOL.0000000000000041

E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf, Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events, JAMA, vol.308, issue.10, pp.1024-1033, 2012.
DOI : 10.1001/2012.jama.11374

J. A. North, A. A. Spector, and G. R. Buettner, Detection of lipid radicals by electron paramagnetic resonance spin trapping using intact cells enriched with polyunsaturated fatty acid, J Biol Chem, vol.267, pp.5743-5746, 1992.

M. Croset and M. Lagarde, In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation, Thromb Haemost, vol.56, pp.57-62, 1986.

M. Croset, Y. Bayon, and M. Lagarde, Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro, Biochem J, pp.281-309, 1992.

M. Croset, M. Guichardant, and M. Lagarde, Different metabolic behavior of long-chain n???3 polyunsaturated fatty acids in human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.961, issue.2, pp.262-269, 1988.
DOI : 10.1016/0005-2760(88)90121-X

D. C. Gaudette and B. J. Holub, Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity, Lipids, vol.96, issue.3, pp.166-169, 1990.
DOI : 10.1007/BF02544332

P. G. Swann, C. A. Parent, M. Croset, P. Fonlupt, M. Lagarde et al., Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function, J Biol Chem, vol.265, pp.21692-21697, 1990.

M. K. Larson, G. W. Tormoen, L. J. Weaver, K. J. Luepke, I. A. Patel et al., Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation, AJP: Cell Physiology, vol.304, issue.3, pp.273-279, 2013.
DOI : 10.1152/ajpcell.00174.2012

E. Véricel, A. Polette, S. Bacot, C. Calzada, and M. Lagarde, Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets, Journal of Thrombosis and Haemostasis, vol.279, issue.3, pp.566-572, 2003.
DOI : 10.1046/j.1538-7836.2003.00076.x

P. M. Kris-etherton, W. S. Harris, and L. J. Appel, Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease, Circulation, vol.106, issue.21, pp.2747-2757, 2002.
DOI : 10.1161/01.CIR.0000038493.65177.94

T. A. Sanders and A. Hinds, The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers, British Journal of Nutrition, vol.314, issue.01, pp.163-173, 1992.
DOI : 10.1016/0021-9150(87)90113-4

M. Aviram, LDL-platelet interaction under oxidative stress induces macrophage foam cell formation, Thromb Haemost Review, vol.74, pp.560-564, 1995.

S. K. Jain, K. S. Krueger, R. Mcvie, J. J. Jaramillo, M. Palmer et al., Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients, Diabetes Care, vol.21, issue.9, pp.1511-1516, 1998.
DOI : 10.2337/diacare.21.9.1511

P. Ferroni, S. Basili, A. Falco, and G. Davi, Oxidant Stress and Platelet Activation in Hypercholesterolemia, Antioxidants <html_ent glyph="@amp;" ascii="&"/> Redox Signaling, vol.6, issue.4, pp.747-756, 2004.
DOI : 10.1089/1523086041361587

E. Véricel, C. Januel, M. Carreras, P. Moulin, and M. Lagarde, Diabetic Patients Without Vascular Complications Display Enhanced Basal Platelet Activation and Decreased Antioxidant Status, Diabetes, vol.53, issue.4, pp.1046-1051, 2004.
DOI : 10.2337/diabetes.53.4.1046

N. Meskini, G. Nemoz, P. Chapuy, P. Haond, J. F. Pageaux et al., Glutathione Peroxidase Activity and Metabolism of Arachidonic Acid in Peripheral Blood Mononuclear Cells from Elderly Subjects, Clinical Science, vol.85, issue.2, pp.85-203, 1993.
DOI : 10.1042/cs0850203

N. Guillot, E. Caillet, M. Laville, C. Calzada, M. Lagarde et al., Increasing intakes of the long-chain ??-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men, The FASEB Journal, vol.23, issue.9, pp.2909-2916, 2009.
DOI : 10.1096/fj.09-133421

URL : https://hal.archives-ouvertes.fr/inserm-00387440

C. Calzada, R. Colas, N. Guillot, M. Guichardant, M. Laville et al., Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men, Atherosclerosis, vol.208, issue.2, pp.467-472, 2010.
DOI : 10.1016/j.atherosclerosis.2009.07.049

URL : https://hal.archives-ouvertes.fr/inserm-00416728

M. Véricel, A. F. Lagarde, and . Prigent, Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis, Br J Nutr, vol.101, pp.852-858, 2009.

E. Véricel, C. Calzada, P. Chapuy, and M. Lagarde, The influence of low intake of n-3 fatty acids on platelets in elderly people, Atherosclerosis, vol.147, issue.1, pp.187-192, 1999.
DOI : 10.1016/S0021-9150(99)00171-9

M. Lagarde, C. Calzada, M. Guichardant, and E. Vericel, Dose-effect and metabolism of docosahexaenoic acid: Pathophysiological relevance in blood platelets, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.88, issue.1, pp.49-52, 2013.
DOI : 10.1016/j.plefa.2012.04.001

URL : https://hal.archives-ouvertes.fr/inserm-00691160

. Lagarde, Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients, Thromb Haemost, vol.114, pp.289-296, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01140217